Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 309

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 309
---
 names in the capacities indicated below any and all further amendments to this registration statement and any other registration
statement filed pursuant to the provisions of Rule 462 under the Securities Act.

Pursuant to the requirements
of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

| Signature             
 /s/ Dr. Eli Hazum     
 Dr. Eli Hazum         |     | Title                                        
 Chief Executive Officer                      
 (Principal Executive Officer)                |     | Date           
 March 10, 2025 |
|:----------------------|:----|:---------------------------------------------|:----|:---------------|
| /s/ Arie Gordashnikov |     | Chief Financial Officer                      |     |                |
| Arie Gordashnikov     |     | -Principal Financial and Accounting Officer  |     | March 10, 2025 |
| /s/ Dr. Ehud Geller   |     | Director, Chairman of the Board of Directors |     |                |
| Dr. Ehud Geller       |     |                                              |     | March 10, 2025 |
| /s/ Jeff Dykan        |     | Director                                     |     |                |
| Jeff Dykan            |     |                                              |     | March 10, 2025 |
| /s/ Keith Valentine   |     | Director                                     |     |                |
| Keith Valentine       |     |                                              |     | March 10, 2025 |

<div align='center'>II-9

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</div>

Pursuant to the requirements of the Securities Act of 1933, as amended,
the undersigned, Puglisi & Associates, the duly authorized representative in the United States of Regentis Biomaterials Ltd., has
signed this Registration Statement on this 10 day of March, 2025.

| Puglisi & Associates           |                   |
| Authorized U.S. Representative |                   |
| /s/ Donald J. Puglisi          |                   |
| Name:                          | Donald J. Puglisi |
| Title:                         | Managing Director |

<div align='center'>II-10</div>